Glen Eagle Advisors’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07K Hold
48
﹤0.01% 969
2026
Q1
$1.31K Hold
48
﹤0.01% 895
2025
Q4
$2K Hold
48
﹤0.01% 884
2025
Q3
$2.21K Hold
48
﹤0.01% 887
2025
Q2
$2.54K Buy
+48
New +$2.54K ﹤0.01% 818
2024
Q2
Sell
-48
Closed -$3.18K 1153
2024
Q1
$3.18K Hold
48
﹤0.01% 847
2023
Q4
$4.71K Hold
48
﹤0.01% 745
2023
Q3
$3.85K Hold
48
﹤0.01% 762
2023
Q2
$3.88K Buy
+48
New +$4.49K ﹤0.01% 770
2022
Q3
Sell
-48
Closed -$6.51K 1101
2022
Q2
$6.51K Buy
+48
New +$7.22K ﹤0.01% 689

Other funds holding CNXC

Glen Eagle Advisors's CNXC Position: Q2 2026 in Review

Glen Eagle Advisors held its Concentrix (CNXC) position steady in Q2 2026 at 48 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #969.

Glen Eagle Advisors first reported a position in CNXC in Q2 2022 and has held it in 10 quarters since. The position peaked at $6.51K in Q2 2022. 273 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • Glen Eagle Advisors held 48 shares of Concentrix worth $1.07K as of Q2 2026.
  • Glen Eagle Advisors left its Concentrix share count unchanged in Q2 2026.
  • Concentrix made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #969 holding.
  • Glen Eagle Advisors first reported a position in Concentrix in Q2 2022 and has held it in 10 quarters since.
  • Glen Eagle Advisors's Concentrix position peaked at $6.51K in Q2 2022.
  • 273 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.